Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suraxavir Marboxil vs oseltamivir in pediatric uncomplicated influenza
ChiCTR2500109395Phase 4Not yet recruiting
- Sponsor
- Children's Hospital of Nanjing Medical University
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of suraxavir marboxil in Influenza A infection, influenza B and influenza (2 arms), sponsored by Children's Hospital of Nanjing Medical University. Primary endpoint: Safety of single-dose Suraxavir Marboxil in Chinese pediatric patients. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
suraxavir marboxil
03
Conditions
Influenza A infectioninfluenza Binfluenza
Beyond the preview
Go deeper on ChiCTR2500109395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500109395.